Delivery Order SPE2DB20D1100-SPE2DB25FC6J2
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency on April 29, 2025, for ZORYVE 0.3% Cream in a 60-gram quantity. This firm fixed-price delivery order, valued at $5,656.30 and due for completion by April 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for ZORYVE 0.15% Cream in a 60-gram size. This firm fixed-price delivery order, valued at $1,018.11, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 29, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream 60GM with a ceiling value of $7,270.70. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing, with a delivery deadline of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This delivery order, valued at $1,329.20, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of ZORYVE 0.3% Cream in 60-gram quantities. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics organization, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is...
- AmerisourceBergen Drug Corp was awarded a $10,928.91 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, for ZORYVE 0.3% Foam 60GM, a pharmaceutical product. The contract carries an ultimate completion date of September 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,991.18 by the Defense Logistics Agency Medical Supply Chain on July 26, 2025. The contract, designated as a firm fixed price delivery order with no set-aside provisions, represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,407.52 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 1, 2025, and represents a child contract under a larger indefinite delivery vehicle. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,908.71 by the Defense Logistics Agency's Medical Supply Chain on June 9, 2025. This non-set-aside, competitively awarded contract carries a firm fixed price structure and an ultimate completion date of June 10, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,473.93 by the Defense Logistics Agency on August 29, 2025, for VTAMA 1% Cream in 60-gram units. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award under open competition. Performance is scheduled for completion by September 2, 2025, with the place of performance located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,268.90 by the Defense Logistics Agency's Medical Supply Chain on June 21, 2025. This firm fixed-price contract, which is not set-aside and represents competitive procurement, is classified as a child order under a larger indefinite delivery contract vehicle. The ultimate completion date is June 23, 2025, with performance taking place at the...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6J2Delivery Order
On June 2, 2025, the Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,858.71 for ZORYVE 0.15% Cream in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Conshohocken, Pennsylvania, leverages its prime IDC with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability in competitively awarded delivery orders across multiple therapeutic domains, ranging from specialty medications to vaccines and medical devices, positioning it as a key supplier within the Defense Logistics Agency's Medical Supply Chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/2/25 |